Cognitive Impairment-Associated Risk Factors of Parkinson's Disease: A Hospital-Based Study in a Cohort of Upper Egypt Parkinson's Patients

认知障碍与帕金森病风险因素:一项基于埃及上部帕金森病患者队列的医院研究

阅读:1

Abstract

Background/Objectives: Cognitive impairment (CI) in Parkinson's disease (PD) is a major burden and significantly affects patients' quality of life. Previous studies found that older age at onset and presence of the akinetic-rigid (AR) subtype are associated with an increased likelihood of CI in PD. The present study aimed to assess factors that are related to the development of CI in PD. Methods: Eighty-three PD patients were consecutively recruited. Demographic information, clinical details, Montreal cognitive assessment (MoCA), Movement Disorder Society Unified Parkinson's Disease Rating Scale (MDS-UPDRS), walking speed, and instrumental activity of daily living (IADL) were assessed. Resting motor threshold (rMT), was also assessed for subgroup of patients with versus without cognitive impairment. Results: According to the MoCA cut-off score of 26, 45 had PD without CI (PD-NCI) (54.22%) and 38 cases (45.78%) had PD with CI (PD-CI). The age and age at onset were significantly older in the PD-CI group (p = 0.006 and 0.018, respectively). The patients were reclassified into AR and tremor-dominant (TR) phenotype. PD-CI patients were more likely to have the AR (81.6%). Walking speed, MDS-UPDRS score, and IADL scores were significantly worse in PD-CI than in PD-NCI. Stepwise linear regression analysis of risk factors associated CI revealed that higher MDS-UPDRS scores, later age of onset, and higher rMT values were considered risk factors for developing CI. Conclusions: Higher UPDRS score, later age of onset, and higher rMT values were considered as risk factors associated CI in PD patients and provide valuable insights for further investigation and potential clinical considerations.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。